Measurement of the patient-side quality after colorectal surgical interventions (MErkE). Clinical study for evaluation of the patient-side quality with reference to fecal and urine incontinence and sexual dysfunction after deep colorectal surgery, as compared to pre- and postoperative.

Measurement of the patient-side quality after colorectal surgical interventions (MErkE). Clinical study for evaluation of the patient-side quality with reference to fecal and urine incontinence and sexual dysfunction after deep colorectal surgery, as compared to pre- and postoperative. - MErkE

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00025156

Enrollment

120

Registered

2021-05-19

Start date

2021-11-15

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C20

Interventions

Group 1: Observational study of patients who meet the stated conditions. Point in time of the questionnaires: 1. round 1a: before the treatment, round 1b: after radiotherapy, preoperative 2. round 2:

By reference to the following questionnaires (- EORTC QLQ - C30 - EORTC QLQ - CR29 - Kontinenz-Score der Chirurgischen Arbeitsgemeinschaft für Coloproktologie (CACP) - International Consultation Inco

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Planned surgery of a rectal adenocarcinoma (ICD-C20) and/ or rectosigmoidal. (ICD-C19) - adequate knowledge of the language - age over 18 - a good physical and mental constitution to allow being part of the study - written consent of the patient

Exclusion criteria

Exclusion criteria: - age under 18 - suffering from dementia or being curated - missing a written consent - occurred surgical interventions of the rectum and the rectosigmoidal passage for example rectopexy - occurred conventional or laparoscopic prostatectomy - occurred radiotherapy of the small basin, except current neoadjuvant therapy - anal cancer, high grade intraepithelial neoplasia or squamous cell cancer - status post gynecological surgery, for example ovarian cancer

Design outcomes

Primary

Measure	Time frame
- Number of fecal incontinence - number of urinary incontinence - number of sexual dysfunction (respectively before and after surgery or else with oder without radiotherapy); by means of questionnaires	—

Secondary

Measure	Time frame
Influence on livability of the following factors: - radiotherapy yes/ no - chemotherapy yes/ no - age, sex - working/ unfit for work/ job-seeking or retired - being in a support group - postoperative complications	—

Countries

Austria, Germany

Contacts

Public ContactThomas Kijak

Siloah St. Trudpert Klinikum, Klinik für Allgemein-, Viszeral-, Thorax- und minimal-invasive Chirurgie

t.kijak@siloah.de072314984701

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026